Pediatric diseases can be complex, and their treatments must be ultra-safe. To avoid side effects, reduce dosages, and report on outcomes, Georgia Tech researchers create complex but small structures – nanoparticles – that have multiple sophisticated functions in the body, such as engaging the immune system to fight infections, and reporting back on the patient’s condition. We help define and advance the field of “Pediatric Nanomedicine” and, with it, the creation of revolutionary new treatments.
Why a new treatment for hRSV? Human respiratory syncytial virus (hRSV) is the leading cause of viral pneumonia,…
This is half of an effort originally funded under the title “Programmed Immune Response and Avoidance with Virus-Like Nanoparticles.” We pivoted…
The primary objective of this proposal is to evaluate whether targeted RNASeq has the potential to assist in the clinical diagnosis of the causes…
Human immunodeficiency virus (HIV) is a causative agent of AIDS, which is a major cause of mortality in all age categories, including children.……
Massive neutrophil infiltration into the airways is a hallmark of the chronic inflammatory response in cystic fibrosis (CF) and occurs even in the…
This technology targets two roles of the CFTR protein: one related to the lethal genetic disease, Cystic Fibrosis (CF), and one related to…